$39.75
1.834.83%
Ult. Agg.: Oct 20, 4:00 PM
$39.75
1.834.83%
Edgewise Therapeutics (EWTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.48 | $-0.49 | $-0.44 | $-0.40 |
| Actual | $-0.53 | $-0.46 | $-0.47 | $-0.39 |
| Surprise | -10.4% | +6.12% | -6.82% | +2.50% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.90 | $-0.42 | $-0.52 | $-0.55 |
| Revenue | ||||
| Consensus | $119.2M | $9.6M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.53 | $-0.48 | -10.4 % |
| Q1 | May 7, 2026 | $-0.46 | $-0.49 | 6.12 % |
| Q4 | Feb 26, 2026 | $-0.47 | $-0.44 | -6.82 % |
| Q3 | Nov 6, 2025 | $-0.39 | $-0.40 | 2.50 % |